|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| C07K 14/001 | (2013.01) | ||
| A61K 9/107 | (2006.01) | ||
| A61K 9/0024 | (2013.01) | ||
| A61K 47/42 | (2017.01) | ||
| A61K 9/06 | (2013.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| C07K 7/08 | (2006.01) | ||
| A61K 38/1774 | (2013.01) | ||
| A61P 37/06 | (2006.01) | ||
| A61K 47/20 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 47/42 | (2013.01) | ||
| A61P 37/06 | (2018.01) | ||
| A61K 47/20 | (2006.01) | ||
| A61K 9/06 | (2006.01) | ||
| C07K 14/00 | (2006.01) |
| (11) | Number of the document | 3787664 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19724994.9 |
| Date of filing the European patent application | 2019-05-03 | |
| (97) | Date of publication of the European application | 2021-03-10 |
| (45) | Date of publication and mention of the grant of the patent | 2024-02-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2019/030656 |
| Date | 2019-05-03 |
| (87) | Number | WO 2019/213562 |
| Date | 2019-11-07 |
| (30) | Number | Date | Country code |
| 201862666471 P | 2018-05-03 | US |
| (72) |
SCHNEIDER, Joel P. , US
MAJUMDER, Poulami , US
RAIMONDI, Giorgio , US
|
| (73) |
The United States of America, as represented by
the Secretary, Department of Health and Human
Services ,
Office of Technology Transfer
National Institutes of Health
6011 Executive Boulevard, Suite 325
MSC 7660, Bethesda, Maryland 20892-7660,
US
The Johns Hopkins University , 3400 N. Charles Street, Baltimore, MD 21218, US |
| (54) | PEPTIDE HYDROGELS FOR DELIVERY OF IMMUNOSUPPRESSIVE DRUGS AND USES THEREOF |
| PEPTIDE HYDROGELS FOR DELIVERY OF IMMUNOSUPPRESSIVE DRUGS AND USES THEREOF |